• Exchange: Berlin
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Generic Pharma

HOS:GR

50.195 EUR 2.532 5.31%

As of 12:43:08 ET on 12/18/2014.

Snapshot for Hospira Inc (HOS)

Open: 48.672 Day's Range: 48.650 - 50.195 Volume: 0
Previous Close: 47.663 52wk Range: 28.995 - 50.515 1-Yr Rtn: +72.67%

Stock Chart for HOS

No chart data available.
  • HOS:GR 48.655
  • 1D
  • 1M
  • 1Y
47.663
Interactive HOS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HOS

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) 24.9129
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) 2.4750
Est. PEG Ratio 1.8645
Market Cap (M EUR) 8,493.10
Shares Outstanding (M) 169.20
30 Day Average Volume 24
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 02/12/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HOS

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for HOS

Hospira, Inc. is a global pharmaceutical and medication delivery company that develops, manufactures and markets products. The Company's portfolio includes generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management products. Hospira products are used by hospitals, clinics, home healthcare providers and long-term care facilities.

F Michael Ball "Mike"Chief Executive OfficerDavid John EndicottPres:Medical Devices
Daphne E JonesSenior VP/CIOBrian J SmithSenior VP/Chief Legal Officer
More Company Profile & Key Executives for HOS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil